![]() |
市场调查报告书
商品编码
1691674
蛋白质体学研究工具与诊断市场(全球)(2024-2030 年)Proteomics Research Tools and Diagnostics Market, Global, 2024-2030 |
蛋白质体学产业呈现转型成长,由蛋白质体学分析和生物标记发现的进步推动
在研究和製药领域的推动下,全球蛋白质体学研究工具和诊断市场预计将在 2024-2030 年间实现高成长并达到重大收益里程碑。精准医疗日益增长的需求以及蛋白质体学在转化研究、生物标记发现和药物开发过程中的显着优势正在推动这一强劲增长。
本报告研究了全球蛋白质体学研究工具和诊断市场,并评估了推动和限制在临床和研究环境中使用蛋白质体学研究工具和诊断的因素。此外,该报告还对北美、欧洲、亚太、拉丁美洲、中东和非洲以及南美 (MEASA) 地区以及每个地区的主要参与企业进行了分析。
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing demand for precision medicine, along with the substantial benefits of proteomics in translational research, biomarker discoveries, and drug development processes, lead to this robust growth.
This analysis assesses the factors driving and restraining the use of proteomics research tools and diagnostics in clinical and research settings. In addition, it offers a regional analysis for North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA); major companies participating in each region are also analyzed. The study also identifies the major growth opportunities by evaluating the industry segments, regulatory environment, and emerging business models, as well as revenues and forecasts.